ArticlePharmaceutical biology2021

Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats.

Huiqi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.